Ordinary Rebalance | Solactive China Healthcare Disruption Index | Effective Date 1st March 2024
Solactive China Healthcare Disruption Index:
In the ordinary rebalance, effective open 01.03.2024 the following index composition was implemented:
3SBIO INC | 0.1653 % |
AKESO INC | 7.9408 % |
ALIBABA HEALTH INFORMATION TECHNOLOGY LTD | 7.6301 % |
ALPHAMAB ONCOLOGY | 0.0635 % |
CANSINO BIOLOGICS INC | 1.7468 % |
CHINA MEDICAL SYSTEM HOLDINGS LTD | 0.4135 % |
CHINA RESOURCES PHARMACEUTICAL | 7.7087 % |
CSPC PHARMACEUTICAL GROUP LTD | 7.2519 % |
GENSCRIPT BIOTECH CORP | 8.2996 % |
GUANGZHOU BAIYUNSHAN PHARMACEUTICAL HOLDINGS CO LTD | 0.4617 % |
HANSOH PHARMACEUTICAL GROUP CO | 7.5579 % |
HUTCHMED CHINA LTD | 0.2765 % |
INNOVENT BIOLOGICS INC | 8.0588 % |
JD HEALTH INTERNATIONAL INC | 0.459 % |
KEYMED BIOSCIENCES INC | 2.3673 % |
LIVZON PHARMACEUTICAL GROUP INC | 0.4654 % |
LUYE PHARMA GROUP LTD | 0.1426 % |
PHARMARON BEIJING CO LTD-H | 0.5174 % |
REMEGEN CO LTD-H | 0.3714 % |
SHANGHAI FOSUN PHARMACEUTICAL GROUP CO LTD | 7.9513 % |
SHANGHAI JUNSHI BIOSCIENCES CO LTD | 0.4201 % |
SHANGHAI MICROPORT MEDBOT GR | 3.4155 % |
SHANGHAI PHARMACEUTICALS HOLDING CO LTD-H | 0.4886 % |
SIMCERE PHARMACEUTICAL GROUP | 0.1906 % |
SINO BIOPHARMACEUTICAL LTD ORD | 7.5309 % |
SKB BIO-B ORD H | 0.1798 % |
WUXI APPTEC CO LTD | 8.8518 % |
WUXI BIOLOGICS CAYMAN INC | 8.7641 % |
YICHANG HEC CHANGJIANG PHA-H | 0.0874 % |
ZAI LAB LTD | 0.2217 % |